These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17015758)

  • 1. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.
    Leng L; Chen L; Fan J; Greven D; Arjona A; Du X; Austin D; Kashgarian M; Yin Z; Huang XR; Lan HY; Lolis E; Nikolic-Paterson D; Bucala R
    J Immunol; 2011 Jan; 186(1):527-38. PubMed ID: 21106847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice.
    Carvalho-Pinto CE; García MI; Mellado M; Rodríguez-Frade JM; Martín-Caballero J; Flores J; Martínez-A C; Balomenos D
    J Immunol; 2002 Jul; 169(2):1058-67. PubMed ID: 12097414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
    Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
    Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice.
    Goulet JL; Griffiths RC; Ruiz P; Spurney RF; Pisetsky DS; Koller BH; Coffman TM
    J Immunol; 1999 Jul; 163(1):359-66. PubMed ID: 10384136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
    J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CX
    Cabana-Puig X; Lu R; Geng S; Michaelis JS; Oakes V; Armstrong C; Testerman JC; Liao X; Alajoleen R; Appiah M; Zhang Y; Reilly CM; Li L; Luo XM
    Inflamm Res; 2023 May; 72(5):1083-1097. PubMed ID: 37060359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus.
    Sekine H; Graham KL; Zhao S; Elliott MK; Ruiz P; Utz PJ; Gilkeson GS
    J Immunol; 2006 Nov; 177(10):7423-34. PubMed ID: 17082662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease.
    Kevil CG; Hicks MJ; He X; Zhang J; Ballantyne CM; Raman C; Schoeb TR; Bullard DC
    Am J Pathol; 2004 Aug; 165(2):609-16. PubMed ID: 15277234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
    Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
    Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
    Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
    Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
    Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
    J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H; Garnier G; Circolo A; Wetsel RA; Ruiz P; Holers VM; Boackle SA; Colten HR; Gilkeson GS
    J Immunol; 2000 Jan; 164(2):786-94. PubMed ID: 10623824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.